Iron deficiency and heart disease: ironclad evidence?

Patients with heart failure have elevated levels of circulating inflammatory cytokines and commonly have iron deficiency anemia or anemia of chronic inflammation. Clinical trials in patients with congestive heart failure and iron deficiency have demonstrated that intravenous iron treatment appears to improve subjective and objective outcomes. Most patients in these trials were not anemic or only had mild anemia, and hemoglobin concentration rose only slightly after treatment with iron. Experimental evidence demonstrates that iron is a cofactor for muscle function, which could explain the improvement in clinical outcomes. Many questions remain to be answered to understand the role of iron therapy in patients with congestive heart failure.

[1]  P. Ponikowski,et al.  Ferric carboxymaltose in patients with heart failure and iron deficiency. , 2009, The New England journal of medicine.

[2]  H. Hillege,et al.  Anemia and mortality in heart failure patients a systematic review and meta-analysis. , 2008, Journal of the American College of Cardiology.

[3]  P. Duarte,et al.  Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. , 2007, Journal of the American College of Cardiology.

[4]  P. Ponikowski,et al.  Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. , 2007, Journal of the American College of Cardiology.

[5]  Jun Ren,et al.  Dietary iron deficiency induces ventricular dilation, mitochondrial ultrastructural aberrations and cytochrome c release: involvement of nitric oxide synthase and protein tyrosine nitration. , 2005, Clinical science.

[6]  Luigi Ferrucci,et al.  Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. , 2004, Blood.

[7]  D. Levy,et al.  Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial Infarction: The Framingham Heart Study , 2003, Circulation.

[8]  Paul W Armstrong,et al.  Anemia Is Common in Heart Failure and Is Associated With Poor Outcomes: Insights From a Cohort of 12 065 Patients With New-Onset Heart Failure , 2003, Circulation.

[9]  B. Psaty,et al.  Elevations of Inflammatory and Procoagulant Biomarkers in Elderly Persons With Renal Insufficiency , 2003, Circulation.

[10]  Anita Deswal,et al.  Cytokines and Cytokine Receptors in Advanced Heart Failure: An Analysis of the Cytokine Database from the Vesnarinone Trial (VEST) , 2001, Circulation.

[11]  G. Brooks,et al.  Iron deficiency: improved exercise performance within 15 hours of iron treatment in rats. , 1990, The Journal of nutrition.

[12]  H. Fillit,et al.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. , 1990, The New England journal of medicine.

[13]  J. Beard,et al.  Interactions of iron deficiency and exercise training in male Sprague-Dawley rats: ferrokinetics and hematology. , 1989, The Journal of nutrition.

[14]  L. Blayney,et al.  The Effects of Iron Deficiency on the Respiratory Function and Cytochrome Content of Rat Heart Mitochondria , 1976, Circulation research.

[15]  R. Person,et al.  Iron deficiency in the rat. Physiological and biochemical studies of muscle dysfunction. , 1976, The Journal of clinical investigation.

[16]  Ganzoni Am,et al.  [Intravenous iron-dextran: therapeutic and experimental possibilities]. , 1970, Schweizerische medizinische Wochenschrift.

[17]  H. Ochs,et al.  Iron deficiency in the rat , 1984 .